glp 1 drugs mechanism of action of GLP-1 agonists – My Endo Consult Current Insights, Advantages and Challenges

Adult-onset type 1 diabetes mellitus differs from the early onset form in terms of residual endogenous insulin secretion, comorbidities and baseline cardiorenal risk

What is it, who is eligible for it, where you can buy it in the UK and more.

Are people going blind from GLP-1 medications

Individualization is Key: The ADA strongly advocates tailoring HbA1c goals based on: Duration of diabetes Risk of hypoglycemia Life expectancy Comorbidities (cardiovascular disease, CKD) Patient preference and treatment burden Beyond HbA1c: Modern diabetes care increasingly integrates Continuous Glucose Monitoring (CGM) metrics such as Time in Range (TIR) alongside HbA1c

What are GLP-1s

Within months of GLP-1 prescriptions written for obesity and overweight, JP Morgan analysts wrote an influential report on the drug category and implications for the health care industryand other sectors, notably food and beverage consumption